These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Progressive Pathological Changes in Neurochemical Profile of the Hippocampus and Early Changes in the Olfactory Bulbs of Tau Transgenic Mice (rTg4510). Kim J; Choi IY; Duff KE; Lee P Neurochem Res; 2017 Jun; 42(6):1649-1660. PubMed ID: 28523532 [TBL] [Abstract][Full Text] [Related]
43. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease. Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679 [TBL] [Abstract][Full Text] [Related]
44. Protective effects of Scutellaria baicalensis Georgi extract on D-galactose induced aging rats. Zhao F; Chang Y; Gao L; Qin X; Du G; Zhang X; Zhou Y Metab Brain Dis; 2018 Oct; 33(5):1401-1412. PubMed ID: 29855978 [TBL] [Abstract][Full Text] [Related]
45. Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction. Plitman E; de la Fuente-Sandoval C; Reyes-Madrigal F; Chavez S; Gómez-Cruz G; León-Ortiz P; Graff-Guerrero A Schizophr Bull; 2016 Mar; 42(2):415-24. PubMed ID: 26320195 [TBL] [Abstract][Full Text] [Related]
46. 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia. Jones RS; Waldman AD Neurol Res; 2004 Jul; 26(5):488-95. PubMed ID: 15265265 [TBL] [Abstract][Full Text] [Related]
47. Regional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies. Graff-Radford J; Boeve BF; Murray ME; Ferman TJ; Tosakulwong N; Lesnick TG; Maroney-Smith M; Senjem ML; Gunter J; Smith GE; Knopman DS; Jack CR; Dickson DW; Petersen RC; Kantarci K Neurobiol Aging; 2014 Jun; 35(6):1483-90. PubMed ID: 24468473 [TBL] [Abstract][Full Text] [Related]
48. Ginsenosides attenuate d-galactose- and AlCl Zhang Y; Pi Z; Song F; Liu Z J Ethnopharmacol; 2016 Dec; 194():188-195. PubMed ID: 27612432 [TBL] [Abstract][Full Text] [Related]
49. Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis. Wang H; Tan L; Wang HF; Liu Y; Yin RH; Wang WY; Chang XL; Jiang T; Yu JT J Alzheimers Dis; 2015; 46(4):1049-70. PubMed ID: 26402632 [TBL] [Abstract][Full Text] [Related]
50. Neuronal marker recovery after Simvastatin treatment in dementia in the rat brain: in vivo magnetic resonance study. Tušková R; Lipták B; Szomolányi P; Vančová O; Uličná O; Sumbalová Z; Kucharská J; Dubovický M; Trattnig S; Liptaj T; Kašparová S Behav Brain Res; 2015 May; 284():257-64. PubMed ID: 25698600 [TBL] [Abstract][Full Text] [Related]
51. NSCs promote hippocampal neurogenesis, metabolic changes and synaptogenesis in APP/PS1 transgenic mice. Zhang W; Gu GJ; Zhang Q; Liu JH; Zhang B; Guo Y; Wang MY; Gong QY; Xu JR Hippocampus; 2017 Dec; 27(12):1250-1263. PubMed ID: 28833933 [TBL] [Abstract][Full Text] [Related]
52. Early-in-life neuroanatomical and behavioural trajectories in a triple transgenic model of Alzheimer's disease. Kong V; Devenyi GA; Gallino D; Ayranci G; Germann J; Rollins C; Chakravarty MM Brain Struct Funct; 2018 Sep; 223(7):3365-3382. PubMed ID: 29948190 [TBL] [Abstract][Full Text] [Related]
53. Effects of Alzheimer's disease transgenes on neurochemical expression in the mouse brain determined by ¹H MRS in vitro. Forster DM; James MF; Williams SR NMR Biomed; 2012 Jan; 25(1):52-8. PubMed ID: 22241671 [TBL] [Abstract][Full Text] [Related]
54. Regional metabolic alterations in Alzheimer's disease: an in vitro 1H NMR study of the hippocampus and cerebellum. Mohanakrishnan P; Fowler AH; Vonsattel JP; Jolles PR; Husain MM; Liem P; Myers L; Komoroski RA J Gerontol A Biol Sci Med Sci; 1997 Mar; 52(2):B111-7. PubMed ID: 9060968 [TBL] [Abstract][Full Text] [Related]
55. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions. Bittner DM; Heinze HJ; Kaufmann J J Alzheimers Dis; 2013; 36(1):155-63. PubMed ID: 23579327 [TBL] [Abstract][Full Text] [Related]
56. Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments. Kaneko I; Morimoto K; Kubo T Neuroscience; 2001; 104(4):1003-11. PubMed ID: 11457586 [TBL] [Abstract][Full Text] [Related]
57. Interactions between in vivo neuronal-glial markers, side of hippocampal sclerosis, and pharmacoresponse in temporal lobe epilepsy. Pimentel-Silva LR; Casseb RF; Cordeiro MM; Campos BAG; Alvim MKM; Rogerio F; Yasuda CL; Cendes F Epilepsia; 2020 May; 61(5):1008-1018. PubMed ID: 32347553 [TBL] [Abstract][Full Text] [Related]
58. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease. Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864 [TBL] [Abstract][Full Text] [Related]
59. Magnetic resonance spectroscopy in Alzheimer's disease: focus on N-acetylaspartate. Chen JG; Charles HC; Barboriak DP; Doraiswamy PM Acta Neurol Scand Suppl; 2000; 176():20-6. PubMed ID: 11261801 [TBL] [Abstract][Full Text] [Related]
60. [Experimental study of hippocampal neuronic lesion in ischemic rat by magnetic resonance spectroscopy]. Lou HY; Zhang MM; Zhang JF; Xu SL; Zhang L Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2007 Feb; 23(1):41-5. PubMed ID: 21171364 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]